Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Diagnostics (Basel, Switzerland)
|
March 14, 2026
Multistep ctDNA Monitoring of Minimal Residual Disease in Colorectal Cancer Liver Metastases: From Tissue NGS to Highly Sensitive Digital PCR Platforms
Izabela Górzyńska, Agata Konieczka, Paweł Gaj, et al.
BMC Research Notes
|
March 15, 2014
Analysis options for high-throughput sequencing in miRNA expression profiling
Tomasz Stokowy, Markus Eszlinger, Michał Świerniak, et al.
Oncotarget
|
April 20, 2017
Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy
Łukasz Koperski, Marta Kotlarek, Michał Świerniak, et al.
Scientific Reports
|
September 1, 2017
Functional analysis of a novel, thyroglobulin-embedded microRNA gene deregulated in papillary thyroid carcinoma
Monika Kolanowska, Anna Wójcicka, Anna Kubiak, et al.
International Journal of Molecular Sciences
|
March 3, 2018
The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary Thyroid Carcinoma
Marta Kotlarek, Anna Kubiak, Małgorzata Czetwertyńska, et al.
International Journal of Molecular Sciences
|
December 28, 2017
NGS Reveals Molecular Pathways Affected by Obesity and Weight Loss-Related Changes in miRNA Levels in Adipose Tissue
Alina Kuryłowicz, Zofia Wicik, Magdalena Owczarz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2015
Association between GWAS-Derived rs966423 Genetic Variant and Overall Mortality in Patients with Differentiated Thyroid Cancer
Michał Świerniak, Anna Wójcicka, Małgorzata Czetwertyńska, et al.
Genes, Chromosomes & Cancer
|
March 7, 2014
Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma
Anna Wójcicka, Małgorzata Czetwertyńska, Michał Świerniak, et al.
Journal of Personalized Medicine
|
April 30, 2021
Compound Haplotype Variants in <i>CFH</i> and <i>CD46</i> Genes Determine Clinical Outcome of Atypical Hemolytic Uremic Syndrome (aHUS)-A Series of Cases from a Single Family
Agnieszka Furmańczyk-Zawiska, Anna Kubiak-Dydo, Ewelina Użarowska-Gąska, et al.
Endokrynologia Polska
|
June 30, 2017
Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma
Dorota Kula, Michał Kalemba, Zbigniew Puch, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Diagnostics (Basel, Switzerland)
|
March 14, 2026
Multistep ctDNA Monitoring of Minimal Residual Disease in Colorectal Cancer Liver Metastases: From Tissue NGS to Highly Sensitive Digital PCR Platforms
Izabela Górzyńska, Agata Konieczka, Paweł Gaj, et al.
BMC Research Notes
|
March 15, 2014
Analysis options for high-throughput sequencing in miRNA expression profiling
Tomasz Stokowy, Markus Eszlinger, Michał Świerniak, et al.
Oncotarget
|
April 20, 2017
Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy
Łukasz Koperski, Marta Kotlarek, Michał Świerniak, et al.
Scientific Reports
|
September 1, 2017
Functional analysis of a novel, thyroglobulin-embedded microRNA gene deregulated in papillary thyroid carcinoma
Monika Kolanowska, Anna Wójcicka, Anna Kubiak, et al.
International Journal of Molecular Sciences
|
March 3, 2018
The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary Thyroid Carcinoma
Marta Kotlarek, Anna Kubiak, Małgorzata Czetwertyńska, et al.
International Journal of Molecular Sciences
|
December 28, 2017
NGS Reveals Molecular Pathways Affected by Obesity and Weight Loss-Related Changes in miRNA Levels in Adipose Tissue
Alina Kuryłowicz, Zofia Wicik, Magdalena Owczarz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2015
Association between GWAS-Derived rs966423 Genetic Variant and Overall Mortality in Patients with Differentiated Thyroid Cancer
Michał Świerniak, Anna Wójcicka, Małgorzata Czetwertyńska, et al.
Genes, Chromosomes & Cancer
|
March 7, 2014
Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma
Anna Wójcicka, Małgorzata Czetwertyńska, Michał Świerniak, et al.
Journal of Personalized Medicine
|
April 30, 2021
Compound Haplotype Variants in <i>CFH</i> and <i>CD46</i> Genes Determine Clinical Outcome of Atypical Hemolytic Uremic Syndrome (aHUS)-A Series of Cases from a Single Family
Agnieszka Furmańczyk-Zawiska, Anna Kubiak-Dydo, Ewelina Użarowska-Gąska, et al.
Endokrynologia Polska
|
June 30, 2017
Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma
Dorota Kula, Michał Kalemba, Zbigniew Puch, et al.
Page
of 2